Imaging evaluation of cystic pancreatic neoplasms

Dushyant Sahani, Onofrio A. Catalano

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cystic lesions of the pancreas have been increasingly diagnosed in recent years and often are discovered at a smaller size than in the past due to increased awareness and improved diagnostic imaging technology. Although all pancreatic tumors, including ductal adenocarcinomas, may undergo central necrosis and appear predominantly cystic, the term cystic neoplasms usually is applied to epithelial lined neoplastic cysts. Pancreatic cystic neoplasms are classified mainly on the basis of their epithelial lining and encompass a wide spectrum of different pathologic entities. Serous cystic neoplasm (SCN), mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN) account for more than 90% of these cases. The remaining 10% are represented by solid pseudopapillary epithelial neoplasm (SPEN), cystic pancreatic endocrine neoplasms (PEN), acinar cell cystadenocarcinomas, cystic metastases, and a few other even rarer tumors [1]. The clinical presentation of pancreatic cystic neoplasms is variable, and a substantial number of pancreatic cysts are discovered incidentally during imaging work-up for an unrelated medical problem. When symptomatic, patients often present with abdominal pain, early satiety, vomiting or jaundice. Occasionally they can present with recurrent pancreatitis when the lesion obstructs or communicates with the pancreatic duct. Advanced cystic malignancies may present with symptoms similar to pancreatic adenocarcinoma, i.e. pain, weight loss and jaundice [1–3]. Many cystic pancreatic masses are resected surgically because of the recognized malignant potential of some cystic neoplasms. However, cystic pancreatic neoplasms represent a spectrum from benign to malignant, and benign lesions are recognized with increasing frequency.

Original languageEnglish
Title of host publicationPancreatic Cancer
PublisherCambridge University Press
Pages83-103
Number of pages21
ISBN (Print)9780511575440, 9780521886925
DOIs
Publication statusPublished - Jan 1 2008

Fingerprint

Pancreatic Neoplasms
Neoplasms
Jaundice
Neoplasms, Cystic, Mucinous, and Serous
Adenocarcinoma
Cystadenocarcinoma
Pancreatic Cyst
Glandular and Epithelial Neoplasms
Acinar Cells
Pancreatic Ducts
Diagnostic Imaging
Pancreatitis
Abdominal Pain
Vomiting
Cysts
Weight Loss
Pancreas
Necrosis
Neoplasm Metastasis
Technology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sahani, D., & Catalano, O. A. (2008). Imaging evaluation of cystic pancreatic neoplasms. In Pancreatic Cancer (pp. 83-103). Cambridge University Press. https://doi.org/10.1017/CBO9780511575440.008

Imaging evaluation of cystic pancreatic neoplasms. / Sahani, Dushyant; Catalano, Onofrio A.

Pancreatic Cancer. Cambridge University Press, 2008. p. 83-103.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sahani, D & Catalano, OA 2008, Imaging evaluation of cystic pancreatic neoplasms. in Pancreatic Cancer. Cambridge University Press, pp. 83-103. https://doi.org/10.1017/CBO9780511575440.008
Sahani D, Catalano OA. Imaging evaluation of cystic pancreatic neoplasms. In Pancreatic Cancer. Cambridge University Press. 2008. p. 83-103 https://doi.org/10.1017/CBO9780511575440.008
Sahani, Dushyant ; Catalano, Onofrio A. / Imaging evaluation of cystic pancreatic neoplasms. Pancreatic Cancer. Cambridge University Press, 2008. pp. 83-103
@inbook{985bc609226e4f14aacc109a3cf07829,
title = "Imaging evaluation of cystic pancreatic neoplasms",
abstract = "Cystic lesions of the pancreas have been increasingly diagnosed in recent years and often are discovered at a smaller size than in the past due to increased awareness and improved diagnostic imaging technology. Although all pancreatic tumors, including ductal adenocarcinomas, may undergo central necrosis and appear predominantly cystic, the term cystic neoplasms usually is applied to epithelial lined neoplastic cysts. Pancreatic cystic neoplasms are classified mainly on the basis of their epithelial lining and encompass a wide spectrum of different pathologic entities. Serous cystic neoplasm (SCN), mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN) account for more than 90{\%} of these cases. The remaining 10{\%} are represented by solid pseudopapillary epithelial neoplasm (SPEN), cystic pancreatic endocrine neoplasms (PEN), acinar cell cystadenocarcinomas, cystic metastases, and a few other even rarer tumors [1]. The clinical presentation of pancreatic cystic neoplasms is variable, and a substantial number of pancreatic cysts are discovered incidentally during imaging work-up for an unrelated medical problem. When symptomatic, patients often present with abdominal pain, early satiety, vomiting or jaundice. Occasionally they can present with recurrent pancreatitis when the lesion obstructs or communicates with the pancreatic duct. Advanced cystic malignancies may present with symptoms similar to pancreatic adenocarcinoma, i.e. pain, weight loss and jaundice [1–3]. Many cystic pancreatic masses are resected surgically because of the recognized malignant potential of some cystic neoplasms. However, cystic pancreatic neoplasms represent a spectrum from benign to malignant, and benign lesions are recognized with increasing frequency.",
author = "Dushyant Sahani and Catalano, {Onofrio A.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1017/CBO9780511575440.008",
language = "English",
isbn = "9780511575440",
pages = "83--103",
booktitle = "Pancreatic Cancer",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Imaging evaluation of cystic pancreatic neoplasms

AU - Sahani, Dushyant

AU - Catalano, Onofrio A.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Cystic lesions of the pancreas have been increasingly diagnosed in recent years and often are discovered at a smaller size than in the past due to increased awareness and improved diagnostic imaging technology. Although all pancreatic tumors, including ductal adenocarcinomas, may undergo central necrosis and appear predominantly cystic, the term cystic neoplasms usually is applied to epithelial lined neoplastic cysts. Pancreatic cystic neoplasms are classified mainly on the basis of their epithelial lining and encompass a wide spectrum of different pathologic entities. Serous cystic neoplasm (SCN), mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN) account for more than 90% of these cases. The remaining 10% are represented by solid pseudopapillary epithelial neoplasm (SPEN), cystic pancreatic endocrine neoplasms (PEN), acinar cell cystadenocarcinomas, cystic metastases, and a few other even rarer tumors [1]. The clinical presentation of pancreatic cystic neoplasms is variable, and a substantial number of pancreatic cysts are discovered incidentally during imaging work-up for an unrelated medical problem. When symptomatic, patients often present with abdominal pain, early satiety, vomiting or jaundice. Occasionally they can present with recurrent pancreatitis when the lesion obstructs or communicates with the pancreatic duct. Advanced cystic malignancies may present with symptoms similar to pancreatic adenocarcinoma, i.e. pain, weight loss and jaundice [1–3]. Many cystic pancreatic masses are resected surgically because of the recognized malignant potential of some cystic neoplasms. However, cystic pancreatic neoplasms represent a spectrum from benign to malignant, and benign lesions are recognized with increasing frequency.

AB - Cystic lesions of the pancreas have been increasingly diagnosed in recent years and often are discovered at a smaller size than in the past due to increased awareness and improved diagnostic imaging technology. Although all pancreatic tumors, including ductal adenocarcinomas, may undergo central necrosis and appear predominantly cystic, the term cystic neoplasms usually is applied to epithelial lined neoplastic cysts. Pancreatic cystic neoplasms are classified mainly on the basis of their epithelial lining and encompass a wide spectrum of different pathologic entities. Serous cystic neoplasm (SCN), mucinous cystic neoplasm (MCN) and intraductal papillary mucinous neoplasm (IPMN) account for more than 90% of these cases. The remaining 10% are represented by solid pseudopapillary epithelial neoplasm (SPEN), cystic pancreatic endocrine neoplasms (PEN), acinar cell cystadenocarcinomas, cystic metastases, and a few other even rarer tumors [1]. The clinical presentation of pancreatic cystic neoplasms is variable, and a substantial number of pancreatic cysts are discovered incidentally during imaging work-up for an unrelated medical problem. When symptomatic, patients often present with abdominal pain, early satiety, vomiting or jaundice. Occasionally they can present with recurrent pancreatitis when the lesion obstructs or communicates with the pancreatic duct. Advanced cystic malignancies may present with symptoms similar to pancreatic adenocarcinoma, i.e. pain, weight loss and jaundice [1–3]. Many cystic pancreatic masses are resected surgically because of the recognized malignant potential of some cystic neoplasms. However, cystic pancreatic neoplasms represent a spectrum from benign to malignant, and benign lesions are recognized with increasing frequency.

UR - http://www.scopus.com/inward/record.url?scp=84926119595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926119595&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511575440.008

DO - 10.1017/CBO9780511575440.008

M3 - Chapter

AN - SCOPUS:84926119595

SN - 9780511575440

SN - 9780521886925

SP - 83

EP - 103

BT - Pancreatic Cancer

PB - Cambridge University Press

ER -